Vita Life Sciences (ASX:VLS) ROCE % : 26.52% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vita Life Sciences's annualized ROCE % for the quarter that ended in Dec. 2024 was 26.52%.

Vita Life Sciences ROCE % Historical Data

The historical data trend for Vita Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences ROCE % Chart

Vita Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

32.99

39.75

31.80

25.24

22.27

Vita Life Sciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															30.45	28.77	27.67	21.90	26.52

Vita Life Sciences ROCE % Calculation

Vita Life Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	12.85	/	( ( (79.01 - 16.216)	+	(71.892 - 19.274) )	/ 2 )
	=	12.85	/	( (62.794	+	52.618)	/ 2 )
	=	12.85	/	57.706
	=	22.27 %

Vita Life Sciences's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	13.464	/	( ( (67.953 - 19.014)	+	(71.892 - 19.274) )	/ 2 )
	=	13.464	/	( ( 48.939	+	52.618 )	/ 2 )
	=	13.464	/	50.7785
	=	26.52 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Vita Life Sciences (ASX:VLS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vita Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines